Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts Sells 600 Shares

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 600 shares of the firm’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $190.76, for a total value of $114,456.00. Following the sale, the executive vice president now directly owns 60,488 shares in the company, valued at approximately $11,538,690.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Johanna Roberts also recently made the following trade(s):

• On Tuesday, September 3rd, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $206.22, for a total value of $123,732.00.
• On Tuesday, August 13th, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $175.98, for a total value of $105,588.00.

Penumbra Price Performance

Penumbra stock opened at $194.73 on Friday. The stock’s 50 day moving average price is $190.58 and its two-hundred day moving average price is $196.07. The stock has a market capitalization of $7.55 billion, a price-to-earnings ratio of 82.16, a PEG ratio of 2.18 and a beta of 0.54. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.77 and a current ratio of 6.25. Penumbra, Inc. has a 52-week low of $148.00 and a 52-week high of $277.34.

Penumbra (NYSE:PEN) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.56 by $0.08. Penumbra had a net margin of 1.26% and a return on equity of 8.39%. The business had revenue of $299.40 million during the quarter, compared to analysts’ expectations of $298.24 million. During the same period last year, the company posted $0.43 earnings per share. The business’s quarterly revenue was up 14.5% on a year-over-year basis. On average, equities analysts predict that Penumbra, Inc. will post 2.59 earnings per share for the current year.

Penumbra declared that its board has authorized a share repurchase program on Tuesday, August 13th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 2.6% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board believes its shares are undervalued.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Leerink Partners initiated coverage on shares of Penumbra in a research report on Tuesday, September 3rd. They set an “outperform” rating and a $263.00 target price on the stock. Piper Sandler decreased their price objective on Penumbra from $260.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, July 31st. Royal Bank of Canada lowered their target price on Penumbra from $289.00 to $205.00 and set an “outperform” rating for the company in a research report on Wednesday, July 31st. Citigroup increased their price target on Penumbra from $178.00 to $200.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Finally, Morgan Stanley lowered their price objective on Penumbra from $235.00 to $210.00 and set an “equal weight” rating for the company in a research report on Monday, July 15th. Six equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $208.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Silvercrest Asset Management Group LLC raised its position in shares of Penumbra by 3.4% during the first quarter. Silvercrest Asset Management Group LLC now owns 1,680 shares of the company’s stock worth $375,000 after purchasing an additional 55 shares during the period. ProShare Advisors LLC increased its stake in Penumbra by 2.9% during the 2nd quarter. ProShare Advisors LLC now owns 2,171 shares of the company’s stock valued at $391,000 after purchasing an additional 62 shares in the last quarter. Arcadia Investment Management Corp MI raised its holdings in Penumbra by 7.9% during the second quarter. Arcadia Investment Management Corp MI now owns 1,006 shares of the company’s stock worth $181,000 after buying an additional 74 shares during the last quarter. Retirement Systems of Alabama lifted its stake in shares of Penumbra by 0.3% in the first quarter. Retirement Systems of Alabama now owns 48,467 shares of the company’s stock valued at $10,817,000 after buying an additional 127 shares in the last quarter. Finally, Mather Group LLC. acquired a new position in shares of Penumbra during the first quarter valued at about $29,000. Institutional investors own 88.88% of the company’s stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.